Dr. Judith L. Swain is currently an A*STAR Senior Fellow of the Agency for Science, Technology and
Research (Singapore), and the Lien Ying Chow Professor of Medicine at the Yong Loo Lin School of
Medicine, National University of Singapore. Previously she served as the Founding Executive Director
of the Singapore Institute for Clinical Sciences within A*STAR.
Prior to coming to Singapore she was the Dean for Translational Medicine and the Founding Director
of the College of Integrated Life Sciences (COILS) at the University of California, San Diego. Dr.
Swain previously served as Chair of the Department of Medicine at Stanford University and held the
Arthur Bloomfield and George E. Becker Professorships there. Prior to her appointment at Stanford,
she was the Herbert C. Rorer Professor of Medical Sciences, Professor of Genetics, and Director of
Cardiovascular Medicine at the University of Pennsylvania. Dr. Swain received her undergraduate
education at the University of California, Los Angeles, and her medical education at the University
of California, San Diego.
She trained in Internal Medicine and Cardiovascular Medicine at Duke University. She then joined the
faculty at Duke where she became widely known in the field of molecular cardiology, and pioneered the
use of transgenic animals to understand the genetic basis of cardiovascular development and disease.
Her current research interests are centered on assessing and enhancing human performance in extreme
environments. She co-founded a center (OptiBrain) with the goal of optimizing brain resources for
performance in extreme environments. This center is collaboration between UC San Diego and the Naval
Health Research Center (San Diego).
In Singapore, Dr. Swain serves on the Board of Directors of the National Healthcare Group, and on
the Board Committee overseeing the Institute of Mental Health. She also serves on the Governing
Council of the Lee Kong Chian School of Medicine, Imperial College/NTU, and on the Academic Oversight
Committee of that Council. Dr. Swain has served in a number of national leadership roles in the U.S.,
including President of the American Society for Clinical Investigation, President of the American
Association of Physicians, and an elected member of the Council of the Institute of Medicine. She
served on the NIH Director’s Standing Committee on Clinical Research, the NIH National Advisory
Research Resources Council and the NRC Commission to evaluate the organization of the National
Institutes of Health. She served as a member of the Defense Science Research Council of DARPA, on
the Board on Army Science and Technology, and as Chair of the Triennial Army Lifesciences and Medical
Laboratory Review for the Assistant Secretary of the Army for Science and Technology. Dr. Swain has
served on international advisory committees including those of the Wellcome Trust, the British Heart
Association, the UK Medical Research Council, and the Canadian Foundation for Innovation. She is
currently a Director of Lexicon Pharmaceuticals and of Avacen, Inc., a member of the SAB for the
Wyss Institute for Biologically Inspired Engineering at Harvard, and a member of the Scientific
Advisory Committee of the Qatar Biomedical Sciences Institute. She serves or has served as a director
or a SAB member for a number of biomedical technology companies, and is co-founder of Synecor, LLC a
medical device accelerator. Dr. Swain has been elected to a number of honorary societies including
the Association of American Physicians, the American Society for Clinical Investigation, Fellow of
the American Association for the Advancement of Science, and the Institute of Medicine.